The purpose of this paper was to determine the effects of laxatives given prior to colonoscopy on 19 clinical chemistry analytes measured in blood.
Differences in clinical chemistry values according to the use of two laxatives for colonoscopy.
Jeong S, Lee SG, Kim Y, Park JR, Kim JH
Purpose
Conclusion
Significant differences exceeding the acceptable bias were observed in 9 and 6 of the 19 clinical chemistry analytes when patients received sodium phosphate formulations (NaPs) or polyethylene glycol–electrolyte lavage solutions (PEG–ELSs), respectively, prior to colonoscopy than in control patients (no colonoscopy or drugs). Further breakdown based on patient age led to similar findings, though some differences in significance were noted. Only glucose levels were not affected by either laxative.
Studies (1)
Purpose
The purpose of this study was to determine the effects of 2 different laxatives given prior to colonoscopy on 19 clinical chemistry analytes in blood. Clinical chemistry results were retrospectively compared among 3239 patients given NaPs before colonoscopy, 1279 patients given PEG-ELSs before colonoscopy, and 4848 patients who did not receive colonoscopy preparation. The authors do not specify the timing of blood draw with respect to colonoscopy.
Summary of Findings
Blood from patients given NaPs prior to colonoscopy had significantly higher inorganic phosphorous (p<0.0001), sodium (p<0.0001), chloride (p<0.0001), creatinine (p<0.0001), uric acid (p<0.0001), cholesterol (p<0.0001), total protein (p<0.0001), albumin (p<0.0001), alkaline phosphate (p=0.0003), aspartate aminotransferase (AST) (p<0.0001), alanine aminotransferase (ALT) (p<0.0001), total bilirubin (p<0.0001), and low-density lipoprotein (LDL) cholesterol (p<0.0001) and lower calcium (p<0.0001), potassium (p<0.0001), blood urea nitrogen (BUN) (p<0.0001), triglycerides (p=0.0391) and high density lipoprotein (HDL) cholesterol (p=0.0228) than control specimens, but only the changes in inorganic phosphorous, calcium, sodium, potassium, chloride, creatinine, total protein, AST and ALT exceeded the acceptable bias. Blood from patients given PEG-ELSs had significantly higher inorganic phosphorous (p<0.0001), sodium (p<0.0001), creatinine (p<0.0001), uric acid (p<0.0001), cholesterol (p<0.0001), AST (p<0.0001), ALT (p<0.0001), total bilirubin (p<0.0001), and LDL cholesterol (p<0.0001) and lower calcium (p=0.0091), potassium (p<0.0001), BUN (p=0.0008), and HDL cholesterol (p=0.0228) than control specimens, but only the bias in inorganic phosphorous, potassium, creatinine, uric acid, AST and total bilirubin exceeded the acceptable bias. When broken down by patient age, trends were the same, but differences in significance and magnitude were observed.
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
NormalNot specifiedPlatforms
Electrolyte/MetalClinical chemistry/auto analyzerSmall moleculeClinical chemistry/auto analyzerCarbohydrateClinical chemistry/auto analyzerSteroidClinical chemistry/auto analyzerLipidClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Other drugs NaPsNonePEG-ELSsPreaquisition Patient age <50 years>50 yearsPreaquisition Surgical procedure type ColonoscopyNone